By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



IDIS House
Churchfield Road
Weybridge    KT13 8DB  United Kingdom
Phone: 44-0-1932-824100 Fax: 44-0-1932-824200



Company News
Cytori Therapeutics, Inc. (CYTX) Enters Agreement With Idis To Launch Managed Access Program In EMEA 1/12/2016 11:54:34 AM
Jeff Thomis Appointed Chairman of the Board of IDIS 9/5/2013 9:20:53 AM
Onyx Pharmaceuticals, Inc. (ONXX) and IDIS Form Partnership to Introduce Carfilzomib Managed Access Program in Europe 8/9/2013 8:28:28 AM
ViroPharma Incorporated (VPHM) and IDIS Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program 12/6/2010 9:41:16 AM
EBD Group, Eurasante, And IDIS Create New International Pharma-Tech Transfer Event 'Biofit' 3/29/2010 9:32:30 AM
Allos Therapeutics, Inc. (ALTH) Announces an Agreement with IDIS for a Named Patient Program for FOLOTYN(TM) (pralatrexate injection) 12/4/2009 10:21:30 AM
Insmed Incorporated (INSM) Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM) 3/30/2009 10:03:08 PM
Cell Therapeutics, Inc. (CTIC) and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 2/10/2009 11:38:17 AM